Cargando…
Paclitaxel: new uses for an old drug
Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancers. Mechanistically, paclitaxel arrests cell cycle and induces cell death by stabilizing microtubules and interfering with microtubule disassembly in cell division. Recently, it has b...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934593/ https://www.ncbi.nlm.nih.gov/pubmed/24591817 http://dx.doi.org/10.2147/DDDT.S56801 |
_version_ | 1782305075477086208 |
---|---|
author | Zhang, Dongshan Yang, Ruhao Wang, Shixuan Dong, Zheng |
author_facet | Zhang, Dongshan Yang, Ruhao Wang, Shixuan Dong, Zheng |
author_sort | Zhang, Dongshan |
collection | PubMed |
description | Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancers. Mechanistically, paclitaxel arrests cell cycle and induces cell death by stabilizing microtubules and interfering with microtubule disassembly in cell division. Recently, it has been found that low-dose paclitaxel seems promising in treating non-cancer diseases, such as skin disorders, renal and hepatic fibrosis, inflammation, axon regeneration, limb salvage, and coronary artery restenosis. Future studies need to understand the mechanisms underlying these effects in order to design therapies with specificity. |
format | Online Article Text |
id | pubmed-3934593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-39345932014-03-03 Paclitaxel: new uses for an old drug Zhang, Dongshan Yang, Ruhao Wang, Shixuan Dong, Zheng Drug Des Devel Ther Perspectives Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy of different types of cancers. Mechanistically, paclitaxel arrests cell cycle and induces cell death by stabilizing microtubules and interfering with microtubule disassembly in cell division. Recently, it has been found that low-dose paclitaxel seems promising in treating non-cancer diseases, such as skin disorders, renal and hepatic fibrosis, inflammation, axon regeneration, limb salvage, and coronary artery restenosis. Future studies need to understand the mechanisms underlying these effects in order to design therapies with specificity. Dove Medical Press 2014-02-20 /pmc/articles/PMC3934593/ /pubmed/24591817 http://dx.doi.org/10.2147/DDDT.S56801 Text en © 2014 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Perspectives Zhang, Dongshan Yang, Ruhao Wang, Shixuan Dong, Zheng Paclitaxel: new uses for an old drug |
title | Paclitaxel: new uses for an old drug |
title_full | Paclitaxel: new uses for an old drug |
title_fullStr | Paclitaxel: new uses for an old drug |
title_full_unstemmed | Paclitaxel: new uses for an old drug |
title_short | Paclitaxel: new uses for an old drug |
title_sort | paclitaxel: new uses for an old drug |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934593/ https://www.ncbi.nlm.nih.gov/pubmed/24591817 http://dx.doi.org/10.2147/DDDT.S56801 |
work_keys_str_mv | AT zhangdongshan paclitaxelnewusesforanolddrug AT yangruhao paclitaxelnewusesforanolddrug AT wangshixuan paclitaxelnewusesforanolddrug AT dongzheng paclitaxelnewusesforanolddrug |